Distinct genomic landscape of non-small cell lung cancer in Bangladeshi patients: Implications for precision oncology in a resource-limited setting.
BACKGROUND Non-small cell lung cancer (NSCLC) is a genetically heterogeneous disease with clinically actionable mutations. Analysis of circulating tumor DNA (ctDNA) in plasma using next-generation sequencing (NGS) provides a minimally invasive method for profiling tumor-associated genomic alterations. However, the ctDN...